Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinoma

Ju Dong Yang, Michael B. Campion, Minetta C. Liu, Roongruedee Chaiteerakij, Nasra H. Giama, Hager Ahmed Mohammed, Xiaodan Zhang, Chunling Hu, Victoria L. Campion, Jin Jen, Sudhakar K. Venkatesh, Kevin C. Halling, Benjamin R. Kipp, Lewis R. Roberts – 19 June 2015 – Circulating tumor cells (CTCs) in blood are associated with poor survival of patients with breast, prostate, or colon cancer. We hypothesized that CTCs are associated with poor survival of patients with cholangiocarcinoma (CCA).

Subscribe to